Analyst Ratings For NASDAQ:NTRP – Neurotrope (NASDAQ:NTRP)
Today, Maxim Group initiated coverage on NASDAQ:NTRP – Neurotrope (NASDAQ:NTRP) with a Buy with a price target of $16.00.
Some recent analyst ratings include
- 5/16/2018-Maxim Group initiated coverage with a Buy rating.
- 3/8/2018-Roth Capital initiated coverage with a Buy ➝ Buy rating.
- 5/2/2017-Aegis Reiterated Rating of Buy.
Recent Insider Trading Activity For NASDAQ:NTRP – Neurotrope (NASDAQ:NTRP)
NASDAQ:NTRP – Neurotrope (NASDAQ:NTRP) has insider ownership of 4.20% and institutional ownership of 13.81%.
- On 3/15/2018 James Gottlieb, Director, sold 314 with an average share price of $8.42 per share and the total transaction amounting to $2,643.88.
- On 12/2/2016 Bruce Bernstein, Director, bought 50,000 with an average share price of $0.28 per share and the total transaction amounting to $14,000.00.
- On 11/23/2016 Kenneth J Gorelick, Director, bought 5,000 with an average share price of $0.29 per share and the total transaction amounting to $1,450.00.
- On 8/26/2016 Kenneth J Gorelick, Director, bought 5,000 with an average share price of $0.41 per share and the total transaction amounting to $2,050.00.
- On 11/23/2015 James Gottlieb, Director, bought 10,000 with an average share price of $0.59 per share and the total transaction amounting to $5,900.00.
Recent Trading Activity for NASDAQ:NTRP – Neurotrope (NASDAQ:NTRP)
Shares of NASDAQ:NTRP – Neurotrope closed the previous trading session at 9.14 up +0.10 1.08% with shares trading hands.
